Invictus MD is a cannabis company founded in Vancouver, Canada.
We represent a platform of licensed producers, under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), dedicated to providing high-quality, regulated pharma-grade cannabis for medical and recreational use. Our growers are supported by over 250 acres of buildable property with full access to our team of industry-leading horticulturists, biochemists, and project managers.
We are committed to raising the professional status quo of this frontier industry. Through clean and organic cultivation practices, deep domain knowledge, and an experienced team to drive it all, Invictus MD is fully-equipped to lead the legal cannabis space, from Canada to the rest of the world.
Dedicated to cultivating the highest in quality
Providing the safest product for our patients is a commitment we take seriously. That’s why every aspect of our growing methodology—the soil, fertiliser, and even how we test for quality—is done in a natural, organic way.
Every step is regulated and standardized in a controlled environment. We combine the latest in monitoring technology with proven agricultural techniques to ensure that every strain coming out of our licensed production facilities meets our high quality standards.
Powering the future of legal marijuana
Invictus MD is strategically positioned to grow alongside the legal cannabis industry as it matures into a mainstream market. Our facilities are fully expandable, which enables our licensed producers to fully meet the exploding demand of both medical and soon to be recreational use.
We plan to continuously innovate our cultivation process and carry out long-term expansion plans to strengthen our production capacity. Our focus is on gaining first-mover advantage as soon as proper legislative regulations liberate the market.
GET OUR INVESTOR DECK
- Breakdown of facilities
- Capitalization structure
- Future Harvest performance
- Company road map from going public
- Combined Cannabis Production Profile
- Management & Board of Directors
Vancouver, BC, May 24, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has closed its previously announced bought deal private placement (the “Offering”), with Canaccord Genuity Corp., Eventus Capital Corp., Echelon Wealth Partners Inc., GMP Securities L.P. and PI Financial […]
VANCOUVER, BC, May 08, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) announces it has determined not to proceed with its previously announced offering of convertible debentures as set forth in a news release dated April 20, 2017 and instead will proceed with an offering of […]
VANCOUVER, BC, May 5, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) Invictus MD is pleased to announce that its management team will visit TSX Venture Exchange (TSXV) on May 5, 2017 and will be opening the trading day.